The company attributes its success to the launch of the EVOLUTION medial-pivot knee system. The international revenues were also strong.
The company’s hip products accounted for $46.269 million, a 3.2 percent increase over last year. The knee products represented $35.112 million, an 11.6 percent growth over last year. Extremity products represented the largest growth, 14.8 percent over last year, and accounted for $34.752 million of the company’s sales.
The biologic products accounted for $19.935 million, representing a 2.5 percent increase over the fourth quarter of 2009.
Read the financial report release from Wright Medical Group (pdf).
Read other coverage on Wright Medical Group:
– Wright Medical Group Launches EVOLUTION Medial-Pivot Knee System
– Wright Medical Group Receives Approval for Testing Ankle Replacement System
– Wright Medical Group Launches Limited Release of Hammertoe Fixation System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
